CLINICAL RESEARCH STUDIES

  1. “A Double-Blind, Parallel Study of the Efficacy and Safety of Calcipotriol Ointment 0.0005% Versus its Vehicle in the Treatment of Plaque Psoriasis, “ Bristol-Myers Squibb Co., 01/91-06/91, Award - $27,150

  2. “A Double Blind Parallel Group Study Utilizing Hematology, Urinalysis Blood and Urine Chemistry and Bone Densitometry to Evaluate the Safety and Efficacy of 0.005% MC 903 ointment verses its Vehicle in the Treatment of Psoriasis," Bristol-Myers Squibb Co., 08/91-03/92, Award - $88,189

  3. “A Randomized Evaluator-Blind, Within-Subject Comparison of the Microanatomical Effects of Lac-Hydrin 12% Lotion, its Vehicle and no Treatment in Subjects with Ichthyosis Vulgaris, “ Bristol-Myers Squibb Co., 01/92-07/92, Award - $32,574

  4. “A Multi-Center, Double-Blind, Controlled Trial Comparing Oral Acyclovir to Oral 256U87 for the Treatment of Herpes Zoster in Immunocompetent Patients 50 Years of Age & Older,” 03/91-09/92

  5. “A Multi-Center, Double-Blind, Controlled Trial Comparing Oral Acyclovir to Oral 256U87 for the Treatment of Herpes Zoster in Immunocompetent Patients Less Than 50 Years Old,” Burroughs Wellcome Co., 03/91-09/92, Award - $121,000

  6. A Double-Blind, Parallel Group Comparison of the Efficacy, Safety and Compatibility of Calcipotriene Ointment 0.005% Along, and in Combination with Halog Ointment 0.1%, Westcort Ointment 0.2% and Hytone Ointment 2.5% in the Treatment of Plaque Psoriasis,” Bristol-Myers Squibb Co., 09/92-01/93, Award - $23,488

  7. “A Randomized, Double-Blind, Parallel Group Comparison of the Efficacy and Safety of Calcipotriene 0.005% Ointment Versus Fluocinonide 0.05% Ointment (Lidex) in the Treatment of Plaque Psoriasis,” Bristol-Myers Squibb Co., 04/93-06/93, Award - $16,625

  8. “An Open, Phase I Tolerance and Efficacy Study of Cytarabine in the One Week Treatment of Condyloma Acuminatum,” Chemex Pharmaceuticals, Inc., 04/93-09/93, Award - $24,993

  9. “A Double-Blind, Vehicle-Controlled, Parallel-Group Study of the Efficacy and Safety of Lac-Hydrin 12% Cream Versus Vehicle in Subjects with Ichthyosis Vulgaris” Bristol-Myers Squibb, 06/93-12/93, Award - $23,625

  10. “A Randomized, Double-Blind Matched-Pair Comparison of Kamillosan Cream vs. Placebo Cream in the Prevention of Radiation Dermatitis of the Ear Pinnae and Subauricolar Fold in Patients Receiving Bilateral Irradiation of the Head,” Asta Medica, Inc., 06/94-10/94, Award - $39,791

  11. “A Double-Blind, Randomized, Vehicle-Controlled Crossover Study Evaluating the Safety and Efficacy of Topical Naloxone Lotion, 0.5%, in Subjects with Pruritic Mycosis Fungoides or Sezary Syndrome,” GenDerm Corp, 06/93-10/94, Award - $33,125

  12. “An Open Label, Compassionate Use Study Monitoring the Long Term Safety and Efficacy of Topical Naloxone Lotion, 0.5% in Subjects with Pruritic Mycosis Fungoides or Sezary Syndrome,” GenDerm Corp., 06/93-06/95

  13. “A Double-Blind, Parallel Study of the Efficacy and Safety of Calcipotriene Cream 0.005% Versus its Vehicle in the Treatment of Plaque Psoriasis,” Bristol-Myers Squibb, 02/94-07/94, Award - $28,000

  14. “An Initial Phase II, Double-Blind, Parallel-Group, Dose-Ranging Study of BMS-181162, 1% and 5% Solutions Versus their Vehicle in the Treatment of Plaque Psoriasis,” Bristol-Myers Squibb, 3/95-09/95, Award - $29,520

  15. “An Initial Phase II, Double-Blind, Parallel-Group, Dose-Ranging Study of BMS-181162 1% and 5% Solutions Versus their Vehicle in the Treatment of Atopic Dermatitis,” Bristol-Myers Squibb, 3/95-06/95, Award - $27,214

  16. “An Open-Label, Multicenter Trial to Evaluate the Safety and Effectiveness of Various Treatment Durations of Terbinafine in Patients with Onychomycosis of the Toenails,” Sandoz, 8/95-12/96, Award - $9,000

  17. “A Comparison of Azelaic Acid 20% Cream Compared with the Vehicle in the Treatment of Individuals with Melasma or Other Forms of Facial Hyperpigmentation,” Allergan Pharmaceutical, 2/96-2/97, Award - $38,805

  18. “Investigator-Masked Study of the Safety and Efficacy of Tazarotene (AGN 190168) 0.1% Gel Plus Corticosteroid Cream or Placebo Cream each Applied Once-Daily for 12 Weeks in the Treatment of Plaque Psoriasis,” Allergen Pharmaceutical, 2/96-1/97, Award - $23,700

  19. “Dovonex (Calcipotriene Ointment) 0.005% in the Treatment of Actinic Keratoses,” Bristol-Myers Squibb, 6/96-10/96, Award - $20,982

  20. “A Clinical Study Evaluating the Safety and Efficacy of Azelaic Acid 20% Cream Used in Combination with M.D. Forte Facial Lotions Compared with Tretinoin 0.025% Cream Used in Combination with a Vehicle in the Treatment of Individuals with Acne Vulgaris,” Allergan Pharmaceutical, 1/97-1/98, Award - $29,243